Trial site
The first affiliated hospital of medical college of zhejiang university
- 16running trials
- 3closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia6 trials
- Acute myeloid leukaemia4 trials
- Childhood cancers4 trials
- Lupus (SLE)3 trials
- Chronic lymphocytic leukaemia2 trials
- Diffuse large B-cell lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Multiple myeloma1 trial
- Myasthenia gravis1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Ovarian cancer1 trial
- Phase
- Early phase 115 trials
- Phase 13 trials
- Phase 21 trial
- Phase 31 trial
- Status
- Recruiting13 trials
- Completed3 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Lead sponsor
- Zhejiang University15 trials
- He Huang4 trials
- Women's Hospital School Of Medicine Zhejiang University1 trial
Running trials
Not yet recruiting
Recruiting
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia
Recruiting
Recruiting
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
Recruiting
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
Not yet recruiting
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
Recruiting
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
Recruiting
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
Recruiting
Recruiting
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
Recruiting
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Recruiting
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Recruiting
Recruiting
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia5 recruiting
- Acute myeloid leukaemia3 recruiting
- Childhood cancers3 recruiting
- Lupus (SLE)3 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
- Myasthenia gravis1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026